Kolexia
Novella Jean-Luc Santé publique
Novella Jean-Luc
Santé publique
Maison Blanche
Reims, France
194 Activités
170 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Démence Maladie d'Alzheimer Fragilité Urgences Maladies neuromusculaires Anémie Fibrillation auriculaire Malnutrition Hypoglycémie

Collaborateurs

Voir plus
Drame Moustapha
Drame Moustapha
Hôpital Pierre Zobda-Quitman, Fort-de-France, France
Jolly Damien
Jolly Damien
Hôpital Robert-Debré Reims, Reims, France
Zulfiqar Abrar-Ahmad
Zulfiqar Abrar-Ahmad
Policlinique Mobile Toktokdoc, Strasbourg, France
Blanchard Francois
Blanchard Francois
Maison Blanche, Reims, France

Industries

Voir plus
Sanofi
4 collaboration(s)
Dernière en 2023
Pfizer
4 collaboration(s)
Dernière en 2022
KPL
2 collaboration(s)
Dernière en 2021
BMS
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL): Comparison of Therapeutic Strategies With Cholinesterase Inhibitors: Stop or Still (SOS) Trial
Essai Clinique (CHU Bordeaux)   05 octobre 2023
Association between hospital admission either directly or via the emergency department, and readmission rates at 30 days in older adults in two rural hospitals: a retrospective cohort study.
Aging clinical and experimental research   07 septembre 2023
Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases.
International journal of molecular sciences   07 avril 2023
Effect of enhanced home support: a retrospective study of the « Ehpad-@-Dom » project.
Geriatrie et psychologie neuropsychiatrie du vieillissement   04 novembre 2022
Frailcoach: Impact of a Telephone Coaching Program on Evolution of Autonomy in Subjects Aged 75 Years or More Living at Home
Essai Clinique (CHU Reims)   08 juillet 2022
HIS2R: Health in Smart Rurality: Impact on Coordination of Care of Telemonitoring and Data Centralization of Frailty Patients
Essai Clinique (CHU Reims)   02 mai 2022
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study.
Alzheimer's & dementia : the journal of the Alzheimer's Association   20 février 2022
Risk Indicators Improve the Prescription Quality of Drugs with Anticholinergic Properties in Nursing Homes.
International journal of environmental research and public health   31 décembre 2021
Study of the impact of MAIA management on the rehospitalisation of patients aged 75 and over.
Geriatrie et psychologie neuropsychiatrie du vieillissement   25 octobre 2021
A qualitative study of the perception of nursing home practitioners about the implementation of quality indicators for drug consumption in nursing homes.
Aging clinical and experimental research   06 octobre 2021